JP Morgan Maintains Overweight on MetLife, Raises Price Target to $96

Benzinga Newsdesk www.benzinga.com Positive 62.0%

Neg 0% Neu 0% Pos 62%

JP Morgan analyst Jimmy Bhullar maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $95 to $96.